Calendar

ACTIVE_NOT_RECRUITINGphase readoutNCT04980404: Inqovi Maintenance Therapy in Myeloid Neoplasms

Sponsor: Massachusetts General Hospital. Phase: PHASE1. Conditions: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05980884: Using Gut Microbial Gbu Gene Testing to Estimate Host TMAO Production Capacity

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Gut Dysbiosis for TMAO Production From L-carnitine Consumption

full page →ctgov ↗

COMPLETEDphase readoutNCT02071784: Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: CADASIL

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03839784: Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient

Sponsor: Stanford University. Phase: . Conditions: Cognitive Decline, Cognitive Change, Cognitive Impairment, Postoperative Delirium, Anesthesia; Reaction, Anesthesia; Adverse Effect

full page →ctgov ↗

SUSPENDEDphase readoutNCT06626633: 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML

Sponsor: University of Maryland, Baltimore. Phase: PHASE1. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗

COMPLETEDphase readoutNCT06608433: Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Healthy Volunteer Study, HPA, Cortisol Deficiency, Adrenal Insufficiency

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07494747: Evaluation of the Effect of the Toothpaste on Delicate Gums

Sponsor: Lacer S.A.. Phase: NA. Conditions: Gingivitis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05837949: Multiple Sclerosis Falls Insight Track

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04547049: A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE3. Conditions: Leukemia, MDS

full page →ctgov ↗

COMPLETEDphase readoutNCT07288658: Comparing the Fit and Performance of Scleral Lenses With Oval and Circular Limbal Zones

Sponsor: University of Waterloo. Phase: PHASE4. Conditions: Limbus Corneae

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02043158: Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Ovarian Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07227558: Improving Information Sharing Between Family Caregivers and Home Care Aides

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Shared Care

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07341048: Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Polycythemia, Polycythemia Vera (PV)

full page →ctgov ↗

RECRUITINGphase readoutNCT06008626: Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

Sponsor: Cryosa, Inc.. Phase: NA. Conditions: Obstructive Sleep Apnea of Adult

full page →ctgov ↗

RECRUITINGphase readoutNCT07139626: Screening of Predictive Biomarkers for Cardiorenal Syndrome

Sponsor: Haiyan Pan. Phase: . Conditions: Cardiorenal Syndrome (CRS)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07138885: A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma

Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC), Second Line Treatment

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03663543: Intravenous Estrogen in Kidney Transplant Study

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Ischemia Reperfusion Injury

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03962543: MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany. Phase: PHASE2. Conditions: Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1)

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT00001215: Genetic Studies of Lysosomal Storage Disorders

Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Lysosomal Storage Disorders, Gaucher Disease, Parkinson Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT06572215: DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve

Sponsor: King's College Hospital NHS Trust. Phase: . Conditions: Chronic Kidney Diseases

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07321535: Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia

Sponsor: Wangjing Hospital, China Academy of Chinese Medical Sciences. Phase: NA. Conditions: Sarcopenia

full page →ctgov ↗

COMPLETEDphase readoutNCT07494708: Hemoglobin Drop and Need for Blood Transfusion in Primary Knee Arthroplasty With or Without Drain Insertion

Sponsor: Shifa International Hospital. Phase: NA. Conditions: Knee Osteoarthritis, Total Knee Arthroplasty

full page →ctgov ↗

RECRUITINGphase readoutNCT07201376: Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: . Conditions: Non-Melanoma Skin Cancer (NMSC), Benign Skin Growth

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07225725: Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)

Sponsor: University of Tennessee. Phase: NA. Conditions: Head and Neck Neoplasms, Emergency Department Presentation, Head and Neck Cancer (H&N)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07544017: Patient Blood Management in Obstetrics

Sponsor: Corniche Hospital. Phase: . Conditions: Patient Blood Management, Blood Product Transfusion for All Conditions

full page →ctgov ↗

COMPLETEDphase readoutNCT07516717: Intrathecal Morphine 75 mcg Versus 100 mcg for Post-Cesarean Analgesia: A Randomized Double-blind Trial

Sponsor: Hospital Universitario de Caracas. Phase: PHASE4. Conditions: Postoperative Pain, Cesarean Section, Obstetric Anesthesia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT01937468: Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Chronic Graft Versus Host Disease, Chronic GVHD, Complications of Organ Transplant Stem Cells

full page →ctgov ↗

RECRUITINGphase readoutNCT06002789: Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: PHASE2. Conditions: Multiple Cancer, Colorectal Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07473089: Swiss Revision Cohort

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Joint (Knee or Hip Replacement), Infection as Complication of Medical Care

full page →ctgov ↗

RECRUITINGphase readoutNCT06581068: Automation of the In Vitro Fertilization Laboratory

Sponsor: Conceivable Life Sciences. Phase: NA. Conditions: Infertility, ART

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07468591: Spinal Cord Stimulation for Refractory Pain Randomized Controlled Trial: the PAcStim RCT

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Chronic Pain Syndrome

full page →ctgov ↗

WITHHELDphase readoutNCT07168174: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗

RECRUITINGphase readoutNCT07233213: An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd.. Phase: PHASE3. Conditions: Primary Immune Thrombocytopenia (ITP)

full page →ctgov ↗

RECRUITINGphase readoutNCT06848660: Study on Orthosis in Cervical Spine Fracture Treatment

Sponsor: Uppsala University Hospital. Phase: NA. Conditions: Cervical Spine Fractures, Cervical Spine Injury, Rigid Collar

full page →ctgov ↗

RECRUITINGphase readoutNCT07428460: Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

Sponsor: Douglas Mental Health University Institute. Phase: NA. Conditions: Schizophrenia and Predominant Negative Symptoms

full page →ctgov ↗

WITHDRAWNphase readoutNCT05829460: Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Endometrial Hyperplasia

full page →ctgov ↗

WITHHELDphase readoutNCT07524660: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗

RECRUITINGphase readoutNCT06818760: Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables

Sponsor: The Cleveland Clinic. Phase: . Conditions: Congenital Heart Disease, Congenital Vascular Disorder, Congenital Cardiomyopathy, Pregnancy Related

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07398560: Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

Sponsor: The Third Affiliated Hospital of Harbin Medical University. Phase: PHASE2. Conditions: Small Cell Lung Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06986460: Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression

Sponsor: Tyler Kaster. Phase: PHASE3. Conditions: Bipolar Depression Depressed Phase

full page →ctgov ↗

RECRUITINGphase readoutNCT05471960: Neuroplasticity in RBD

Sponsor: University of Minnesota. Phase: NA. Conditions: REM Sleep Behavior Disorder

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT06560021: Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: NA. Conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis

full page →ctgov ↗

RECRUITINGphase readoutNCT05724121: Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia, Mantle Cell Lymphoma, Sudden Cardiac Death, Cardiac Arrhythmias, Hematologic Malignancies

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02656706: Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma

Sponsor: Brown University. Phase: PHASE2. Conditions: Melanoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07430904: Empowerment Program to Reduce Treatment of Asymptomatic Bacteriuria in Veterans With Spinal Cord Injury

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Spinal Cord Injury, Spinal Cord Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT07095933: The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

Sponsor: Xuanwu Hospital, Beijing. Phase: EARLY_PHASE1. Conditions: Epilepsy, Drug Resistant

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06161584: A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Sponsor: Apellis Pharmaceuticals, Inc.. Phase: . Conditions: Geographic Atrophy

full page →ctgov ↗

RECRUITINGphase readoutNCT07509333: MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients

Sponsor: West China Hospital. Phase: NA. Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Elderly

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07448233: Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas

Sponsor: Xijing Hospital. Phase: NA. Conditions: Epilepsies, Remote Management of Epilepsy in Rural Areas

full page →ctgov ↗

COMPLETEDphase readoutNCT02410733: Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma

Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Melanoma

full page →ctgov ↗

Date TBD